Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #51,551 to #51,600.
- Neurofibromatosis type 1 CT scan (3 revisions)
- Neurofibromatosis type 1 classification (3 revisions)
- Neurofibromatosis type 1 history and symptoms (3 revisions)
- Neurofibromatosis type 1 secondary prevention (3 revisions)
- Neurofibromatosis type II (3 revisions)
- Neurofilament (3 revisions)
- Neurogenic bladder (patient information) (3 revisions)
- Neurogenic inflammation (3 revisions)
- Neurogenins (3 revisions)
- Neuroglobin (3 revisions)
- Neurokinin A (3 revisions)
- Neuroligin (3 revisions)
- Neuromedin U receptor 1 (3 revisions)
- Neuromedin U receptor 2 (3 revisions)
- Neuromuscular junction disease (3 revisions)
- Neuron-Specific Enolase (NSE) (3 revisions)
- Neuropeptide B/W receptor (3 revisions)
- Neuropeptide FF receptor (3 revisions)
- Neuropeptide FF receptor 1 (3 revisions)
- Neuropeptide Y receptor (3 revisions)
- Neuropilin 1 (3 revisions)
- Neuroscience (3 revisions)
- Neurosurgery (3 revisions)
- Neurosyphilis CT scan (3 revisions)
- Neurosyphilis case study one (3 revisions)
- Neurosyphilis cost-effectiveness of therapy (3 revisions)
- Neurosyphilis future or investigational therapies (3 revisions)
- Neurotensin receptor (3 revisions)
- Neurotensin receptor 2 (3 revisions)
- Neutron (3 revisions)
- Neutropenia primary prevention (3 revisions)
- Newcastle disease (3 revisions)
- Niacin/lovastatin indications and usage (3 revisions)
- Niacin/lovastatin use in specific populations (3 revisions)
- Nibrin (3 revisions)
- Nicergoline (3 revisions)
- Niclosamide indications (3 revisions)
- Nicotinamide phosphoribosyltransferase (3 revisions)
- Nicotinic antagonist (3 revisions)
- Nicotinyl methylamide (3 revisions)
- Niemann-Pick disease differential diagnosis (3 revisions)
- Niemann-Pick disease physical examination (3 revisions)
- Niflumic acid (3 revisions)
- Nifurtoinol (3 revisions)
- Nikethamide (3 revisions)
- Ninein (3 revisions)
- Nipah virus encephalitis (patient information) (3 revisions)
- Nipocalimab-aahu (3 revisions)
- Nisch syndrome (3 revisions)
- Nitazoxanide adverse reactions (3 revisions)